trial · primary record
Carboplatin
Recurrent Hodgkin Lymphoma
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 78 |
| Primary completion | 2027-04-30 |
| Primary endpoint | Complete Response Rate by Lugano Classification |
| Registry ID | NCT03016871 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:23.466Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03016871
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Carboplatin · approval
- Carboplatin · compound